Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT00941928 · TERMINATED
Trial details
- NCT number
- NCT00941928
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-05-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.